BRAF and neoplasm: Finally, in all samples analyzed by single staining, no statistically significant correlation was found between the number of CD3+, CD8+, FOXP3+, GRBZ+ immune cells or PD-L1 expression on tumor cells and the clinicopathological features, including BRAF mutational status.